Table 4 Significant robust results of the third round two-sample Mendelian randomization analyses.
Exposure | Outcome | SNPs | IVW | MR-Egger | WM | MR-RAPS | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  | OR (95% CI) | P value | Power | Cochran Q statistics (df) | P value | OR (95% CI) | P value | Power | Intercept (Se) | P value | Cochran Q statistics (df) | P value | OR (95% CI) | P value | Power | OR (95% CI) | P value | Power |
ECLs | Carpal tunnel syndrome | 12 | 1.041 (1.007 1.075) | 0.018 | 0.62 | 6.792 (11) | 0.816 | 1.024 (0.968 1.083) | 0.426 | 0.27 | 0.005 (0.007) | 0.507 | 6.318 (10) | 0.788 | 1.033 (0.988 1.080) | 0.153 | 0.45 | 1.042 (1.005 1.080) | 0.024 | 0.64 |
Compression fracture | 12 | 0.841 (0.748 0.945) | 0.004 | 0.79 | 5.706 (11) | 0.892 | 0.862 (0.668 1.113) | 0.283 | 0.67 | −0.006 (0.026) | 0.831 | 5.658 (10) | 0.843 | 0.807 (0.693 0.941) | 0.006 | 0.92 | 0.838 (0.740 0.949) | 0.005 | 0.81 |